Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
17.03
-1.34 (-7.29%)
Mar 31, 2025, 10:57 AM EDT - Market open
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.89 billion as of March 31, 2025. Its market cap has decreased by -37.43% in one year.
Market Cap
2.89B
Enterprise Value
2.75B
1-Year Change
-37.43%
Ranking
Category
Stock Price
$17.03
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.89B, an increase of 2,225.81%. That is a compound annual growth rate of 72.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |